The hydroxychloroquine debate: a therapeutic dilemma for general practitioners - Archive ouverte HAL Access content directly
Journal Articles European Journal of Public Health Year : 2021

The hydroxychloroquine debate: a therapeutic dilemma for general practitioners

(1, 2, 3) , (4) , (5) , (3, 2)
1
2
3
4
5

Abstract

France has been at the epicenter of the worldwide debate about hydroxychloroquine, as the main advocacy for its use to treat COVID-19 comes from a research unit led by Didier Raoult in Marseille. Among a national panel of 2940 general practitioners, we found that physicians in the areas most strongly affected by the epidemic or closest to the epicenter of the controversy reported that the hydroxychloroquine debate had made it difficult for them to deal with patients' treatment requests. Their adherence to official recommendations was also lower. It will be necessary to examine the conditions producing so strong a conflict.
Fichier principal
Vignette du fichier
ckab002bis.pdf (123.07 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03334318 , version 1 (06-09-2021)

Identifiers

Cite

Romain Lutaud, Dimiti Scronias, Jeremy K Ward, Pierre Verger. The hydroxychloroquine debate: a therapeutic dilemma for general practitioners. European Journal of Public Health, 2021, 31 (2), pp.283-285. ⟨10.1093/eurpub/ckab002⟩. ⟨hal-03334318⟩
83 View
41 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More